These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23734391)

  • 21. Commentary on Bruneau et al. (2012): injection of prescription opioid pain relievers and infectious disease risk.
    Hadland SE; Wood E
    Addiction; 2012 Jul; 107(7):1328-9. PubMed ID: 22672378
    [No Abstract]   [Full Text] [Related]  

  • 22. Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.
    Kikvidze T; Luhmann N; Avril E; Butsashvili M; Labartkava K; Etienne A; Le Pluart D; Inaridze I; Gamezardashvili A; Kharshiladze D; Bouscaillou J
    Int J Drug Policy; 2018 Feb; 52():16-19. PubMed ID: 29227878
    [No Abstract]   [Full Text] [Related]  

  • 23. State of the art science addressing injecting drug use, HIV and harm reduction.
    Beg M; Strathdee SA; Kazatchkine M
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S1-4. PubMed ID: 25727257
    [No Abstract]   [Full Text] [Related]  

  • 24. The value of harm reduction for injection drug use: A clinical and public health ethics analysis.
    Greenberg M
    Dis Mon; 2019 May; 65(5):118. PubMed ID: 30718005
    [No Abstract]   [Full Text] [Related]  

  • 25. Russian Federation: Duma repeals Russian Criminal Code reforms.
    Franklin T
    HIV AIDS Policy Law Rev; 2006 Apr; 11(1):32, 35. PubMed ID: 16805018
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C, interferon alpha and psychiatric co-morbidity in intravenous drug users (IVDU) : guidelines for clinical practice.
    De Bie J; Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):68-80. PubMed ID: 15832590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons.
    Lafferty L; Wild TC; Rance J; Treloar C
    Harm Reduct J; 2018 Aug; 15(1):39. PubMed ID: 30075728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple parameter evidence synthesis--a potential solution for when information on drug use and harm is in conflict.
    Hickman M; De Angelis D; Jones H; Harris R; Welton N; Ades AE
    Addiction; 2013 Sep; 108(9):1529-31. PubMed ID: 23600694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis C--the forgotten epidemic].
    Meyer R
    Dtsch Med Wochenschr; 2006 Oct; Suppl 1():68. PubMed ID: 17598256
    [No Abstract]   [Full Text] [Related]  

  • 30. Trend Analyses of Users of a Syringe Exchange Program in Philadelphia, Pennsylvania: 1999-2014.
    Maurer LA; Bass SB; Ye D; Benitez J; Mazzella S; Krafty R
    AIDS Behav; 2016 Dec; 20(12):2922-2932. PubMed ID: 27066985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Policy change towards implementing harm reduction in Sub-Saharan Africa.
    Abdool R
    Int J Drug Policy; 2016 Apr; 30():140-2. PubMed ID: 27017377
    [No Abstract]   [Full Text] [Related]  

  • 32. [Illegal drug users and risk factors for HIV and HCV infection].
    Backmund M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Apr; 50(4):471-5. PubMed ID: 17377722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injecting drug use in India and the need for policy and program change.
    Panda S; Kumar MS
    Int J Drug Policy; 2016 Nov; 37():115-116. PubMed ID: 27771524
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV/AIDS harm reduction in Iran.
    Razzaghi E; Nassirimanesh B; Afshar P; Ohiri K; Claeson M; Power R
    Lancet; 2006 Aug; 368(9534):434-5. PubMed ID: 16890814
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gaps in Hepatitis C Care of People Who Use Drugs].
    Bruggmann P
    Praxis (Bern 1994); 2017; 106(7):359-363. PubMed ID: 28357908
    [No Abstract]   [Full Text] [Related]  

  • 36. Foreword: illicit drugs in Central Asia.
    Kazatchkine M
    Int J Drug Policy; 2014 Nov; 25(6):1153. PubMed ID: 25261111
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic hepatitis C?].
    Krook AL
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2801-2. PubMed ID: 15534686
    [No Abstract]   [Full Text] [Related]  

  • 38. Pence, Putin, Mbeki and Their HIV/AIDS-Related Crimes Against Humanity: Call for Social Justice and Behavioral Science Advocacy.
    Kalichman SC
    AIDS Behav; 2017 Apr; 21(4):963-967. PubMed ID: 28130629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Matthews AM; Fireman M; Zucker B; Sobel M; Hauser P
    Am J Psychiatry; 2006 Aug; 163(8):1342-7; quiz 1479. PubMed ID: 16877644
    [No Abstract]   [Full Text] [Related]  

  • 40. Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users.
    Zwahlen M; Vlahov D
    Int J Epidemiol; 2003 Oct; 32(5):715-6. PubMed ID: 14559737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.